
Profound Medical Corp
PROFTORONTO STOCK EXCHANGEKey Statistics
Open
$6.89
Day High
$6.93
Day Low
$6.75
Prev. Close
$6.90
VolumeShares traded today.
27.95K
Avg. VolumeAverage daily volume.
—
Market CapTotal value of all shares = price × shares outstanding.
$247.46M
P/E (TTM)Price-to-Earnings: share price ÷ earnings per share over the last 12 months. Lower can mean cheaper; very high can mean growth expectations.
-5.45
Forward P/EP/E based on forecast next-year earnings.
—
P/B RatioPrice-to-Book: share price ÷ book value per share.
—
52W HighHighest price over the past 52 weeks.
$8.95
52W LowLowest price over the past 52 weeks.
$3.76
50D MAAverage closing price over the last 50 trading days.
$6.58
200D MAAverage closing price over the last 200 trading days.
$6.32
Dividend YieldAnnual dividend ÷ share price, as a %.
—
BetaVolatility vs the market. >1 = more volatile than the S&P 500.
—
Performance
1W
-2.3%1M
+4.0%6M
+4.8%YTD
-11.1%1Y
+24.0%About
Sonalleve MR-HIFU is a medical system developed by Philips Healthcare for the treatment of uterine fibroids without surgery. The system uses non-invasive high-intensity focused ultrasound (HIFU) guided by magnetic resonance (MR), hence the acronym MR-HIFU. The procedure involves volumetric heating of fibroids with real-time feedback. In June 2017, Philips and Profound Medical announced an agreement to transfer Philips' MR-HIFU business, which includes the Sonalleve system, to Profound Medical.
profoundmedical.com/Company Facts
Similar stocks
Health CareSentiment
Latest News
Social Noise
Price Alerts
Loading…
Trade PROF
Brokers available in your region (US)
Affiliate links — we may earn a commission. CFDs are risky.